-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Acurx Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate for Q1 2024.
- Acurx Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $4.51M.
- Acurx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $8.16M, a 121% increase from 2022.
- Acurx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3.7M, a 75% decline from 2021.
- Acurx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $14.8M, a 266% increase from 2020.